Event Type: Seminar
- Location Name:
- Reed Smith's New York office, 599 Lexington Avenue, New York, NY 10022
- Start Date/Time:
- 16 October 2019, 10:00 AM EDT
- End Date/Time:
- 16 October 2019, 2:00 PM EDT
Welcome, introductions and announcements (10:00 – 10:15 am)
I. The CBD Marketing Minefield (10:15 – 10:45 am)
Cori Goldberg, a Partner at Reed Smith, will present an overview of current federal (FDA, USDA) and state regulations for CBD and CBD products and what that means for businesses. Specifically, she will cover the implications for food, drug, dietary supplement, and cosmetic companies and discuss the risks of putting into interstate commerce – and advertising having done so - products in those categories that contain CBD.
Cori Goldberg, Partner, Reed Smith LLP
II. ANA Government Relations and Legal Updates (10:45 am – 11:45 pm)
A. The Mandatory Disclosure Muddle (10:45 – 11:15 am)
The Department and Health and Human Services has appealed the decision that threw out its rule regarding mandatory disclosures in televised prescription drug ads. Meanwhile, we should know in a few months whether the Supreme Court will take an appeal from the Ninth Circuit on it’s decision upholding a mandatory disclosure ordinance relating to cell phones from Berkeley, California. Will the courts provide more clarity than we have now? Dan Jaffe will discuss.
B. State Privacy (11:15 – 11:45 am)
Most of the state legislatures have wrapped up for 2019 – but California’s Attorney General is busy working on the regulations governing the California Consumer Privacy Act, which takes effect in under three months. ANA has set up a working group that is following the implementation process and providing a forum for our members to share intel and best practices. We’ll discuss how ANA is responding.
Dan Jaffe, Group Executive Vice President, Government Relations, ANA
Chris Oswald, Senior Vice President, Government Relations, ANA